We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00252395
First Posted: November 11, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Health Canada
Information provided by:
Sunnybrook Health Sciences Centre
November 9, 2005
November 11, 2005
December 9, 2005
August 2005
Not Provided
Total prescribing error, as measured by the number of call backs received from pharmacists.
Same as current
No Changes Posted
  • a) Interactions
  • b) Dosing and route of administration errors
  • c) Pack errors
  • d) Legibility errors
Same as current
Not Provided
Not Provided
 
Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics
Effects of Electronic Prescribing on Safety and Quality in Hospital-Based Ambulatory Are: a Randomised Controlled Trial

All reliably evaluated POE systems to date have been desktop computer based, but now there is widespread use and acceptance among physicians of PDA devices for a variety of purposes. Clinicians report that drug information on a PDA improved their access to information and efficiency while reducing their self perceived error rates6. The use of these devices for information retrieval in clinical settings is expected to grow as wireless communication becomes more ubiquitous and as more applications become available6,7. During the past decade there has been a growing awareness of several issues aimed at promoting safer health care for our patients – point of care information technology is one of the keys.

To this end we have worked with a Canadian company, Drugmagnet, to develop and implement PDA-based electronic prescribing system within a major Canadian academic health centre. This is a cluster randomised trial, in which access to and use of the e-prescribing system is switched on and off for randomly chosen weeks, thus time serves as the randomized element.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Educational/Counseling/Training
Electronic Prescribing
Device: PDA-based Electronic Prescribing Software
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
August 2006
Not Provided

Inclusion Criteria:

  • active staff physician at Sunnybrook & Women's College HSC

Exclusion Criteria:

  • inadequate prescribing practice (minimum number)
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00252395
S&W e-RX
6804-15-2003/5590024
Not Provided
Not Provided
Not Provided
Not Provided
Sunnybrook Health Sciences Centre
Health Canada
Study Director: Merrick F Zwarenstein, MBBCH Institute for Clinical Evaluative Science
Principal Investigator: William J Sibbald, MD, MPH Sunnybrook & Women's College Health Sciences Centre
Sunnybrook Health Sciences Centre
November 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP